Lilly defends blockbuster Alimta with unusual ammo

By Ransdell Pierson (Reuters) - Eli Lilly and Co, now facing one of the worst patent cliffs in its history, could find $15 billion in sorely needed relief if it beats the odds and wins a closely watched patent battle with generic drugmaker Teva Pharmaceutical Industries. While a Lilly victory is not widely expected, a number of patent attorneys and industry analysts say the patent being challenged by Teva, beginning Monday in Indianapolis federal court, will pass legal muster. The U.S. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/lilly-defends-blockbuster-alimta-unusual-ammo-170525110.html